Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Anker

Showing results (31-40 of 184) with videos related to

Pageof 19
Sort By:
The New England Journal of Medicine|October 5, 2018
Enzalutamide in Castration-Resistant Prostate CancerMarkus S Anker, Lorenz H Lehmann, Stefan D Anker
Journal of Cachexia, Sarcopenia and Muscle|November 29, 2016
Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016Stephan von Haehling, Markus S Anker, Stefan D Anker
ESC Heart Failure|December 31, 2019
The difference in referencing in Web of Science, Scopus, and Google ScholarMarkus S Anker, Sara Hadzibegovic, Alessia Lena, et al.
ESC Heart Failure|December 21, 2018
Metabolic disorders in heart failure and cancerAlessia Lena, Andrew J S Coats, Markus S Anker
The New England Journal of Medicine|May 19, 2017
Bariatric Surgery or Intensive Medical Therapy for Diabetes after 5 YearsMarkus S Anker, Stephan von Haehling, Stefan D Anker
The New England Journal of Medicine|May 19, 2016
Weight Loss and Health Status after Bariatric Surgery in AdolescentsStefan D Anker, Markus S Anker, Stephan von Haehling
Kardiologia Polska|March 27, 2019
Novel biomarkers in heart failure and cardio-oncologyMarkus S Anker, Stephan von Haehling, Stefan D Anker
ESC Heart Failure|October 29, 2020
ESC Heart Failure increases its impact factorMarkus S Anker, Zoltán Papp, Gábor Földes, et al.
Expert Opinion on Drug Discovery|October 3, 2025
New models for cancer cachexia and their application to drug discoveryRyosuke Sato, Markus S Anker, Jochen Springer, et al.
JACC. Cardiooncology|February 19, 2025
Growth Differentiation Factor-15: A Promising Biomarker and Target in Cancer PatientsMarkus S Anker, Lars Bullinger, Ulrich Keller, et al.
Pageof 19

Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
The New England Journal of Medicine|October 5, 2018
Enzalutamide in Castration-Resistant Prostate CancerMarkus S Anker, Lorenz H Lehmann, Stefan D Anker
Journal of Cachexia, Sarcopenia and Muscle|November 29, 2016
Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016Stephan von Haehling, Markus S Anker, Stefan D Anker
ESC Heart Failure|December 31, 2019
The difference in referencing in Web of Science, Scopus, and Google ScholarMarkus S Anker, Sara Hadzibegovic, Alessia Lena, et al.
ESC Heart Failure|December 21, 2018
Metabolic disorders in heart failure and cancerAlessia Lena, Andrew J S Coats, Markus S Anker
The New England Journal of Medicine|May 19, 2017
Bariatric Surgery or Intensive Medical Therapy for Diabetes after 5 YearsMarkus S Anker, Stephan von Haehling, Stefan D Anker
The New England Journal of Medicine|May 19, 2016
Weight Loss and Health Status after Bariatric Surgery in AdolescentsStefan D Anker, Markus S Anker, Stephan von Haehling
Kardiologia Polska|March 27, 2019
Novel biomarkers in heart failure and cardio-oncologyMarkus S Anker, Stephan von Haehling, Stefan D Anker
ESC Heart Failure|October 29, 2020
ESC Heart Failure increases its impact factorMarkus S Anker, Zoltán Papp, Gábor Földes, et al.
Expert Opinion on Drug Discovery|October 3, 2025
New models for cancer cachexia and their application to drug discoveryRyosuke Sato, Markus S Anker, Jochen Springer, et al.
JACC. Cardiooncology|February 19, 2025
Growth Differentiation Factor-15: A Promising Biomarker and Target in Cancer PatientsMarkus S Anker, Lars Bullinger, Ulrich Keller, et al.
Pageof 19